Benzinga | Jan 26, 2022 04:31PM EST

Edwards Lifesciences Q4 EPS $0.53 Misses $0.55 Estimate, Sales $1.33B Miss $1.36B Estimate

Edwards Lifesciences (NYSE:EW) reported quarterly earnings of $0.53 per share which missed the analyst consensus estimate of $0.55 by 3.64 percent. This is a 6 percent increase over earnings of $0.50 per share from the same period last year. The company reported quarterly sales of $1.33 billion which missed the analyst consensus estimate of $1.36 billion by 2.23 percent. This is a 11.55 percent increase over sales of $1.19 billion the same period last year.